Biotech - Providence Business News

Resilient Rhody needs a strong workforce

Digital Special Editions 08/14/2026

For 40 years, Providence Business News has been reporting on the economic and workforce changes, challenges and milestones that have helped shape the Rhode...

Driving Forces: William C. Tsonos

Digital Special Editions 08/14/2026

William C. Tsonos Beacon Bank Rhode Island market president Relationships matter in communities and business, and William C. Tsonos has spent a lifetime building them in...

PLAY AREA: State Rep. David J. Place, R-Burrillville, would like to create a “regulatory sandbox” for biotech firms in the state where a waiver of certain regulations could be approved for activities such as testing, but the proposal has faced pushback from some state agencies. Place stands outside the CCI building in Providence, where some life science firms are located.  PBN PHOTO/MATTHEW MCNULTY

Biotech ‘sandbox’ bill raises oversight concerns

Focus 04/24/2026

With Rhode Island making a push for the state to become a burgeoning hub for life sciences and biotechnology firms by building lab space...

MASSACHUSETTS-BASED BIOTECHNOLOGY FIRM Organogenesis has requested tax incentives in order to establish a manufacturing facility at the former Rubius Therapeutics facility in Smithfield. This a screenshot of the property listing on Loopnet.com. / SCREENSHOT OF LOOPNET.COM

Mass.-based biotech firm looks to expand to former Rubius facility in Smithfield

Economy 10/30/2024

PROVIDENCE – A Massachusetts-based biotechnology firm is seeking to spend $97.5 million to establish a manufacturing operation at the former Rubius Therapeutics facility in...

DOWN TO A SCIENCE: Neil D. Steinberg, second from right, chair of the R.I. Life Sciences Hub, speaks during a panel discussion on the state’s life sciences sector at Providence Business News’ 2024 Emerging Industries Summit at the Providence Marriott on March 13. Also on the panel are, from left, Dr. Gaurav Choudhary, medical director of Lifespan Corp.’s Cardiovascular Institute clinical trials office; Justin Fallon, Brown University professor and founder of biotech company Bolden Therapeutics Inc.; and Carol Malysz, executive director of RI Bio. PBN Editor Michael Mello, standing at right, moderates. PBN PHOTO/MIKE SKORSKI

Panel: R.I. biotech sector has catching up to do

Economy 03/29/2024

Like most leading voices in Rhode Island’s emerging life sciences sector, Neil D. Steinberg doesn’t try to deceive himself on Rhode Island’s standing in...

Amgen reports $767M profit in Q4 despite declining sales of Enbrel

Economic Activity 02/07/2024

WEST GREENWICH – Amgen Inc. on Tuesday reported fourth-quarter earnings of $767 million despite declining sales for Enbrel, the rheumatoid-arthritis drug that is manufactured...

Report: Life sciences industry has room to grow in R.I.

Economic Activity 06/07/2023

PROVIDENCE – A $45 million investment to jump-start the Ocean State's position in the booming life sciences industry was left intact when the House Finance...

EpiVax, Greenlight partner to produce mRNA cancer treatments

Entrepreneurship 01/09/2023

PROVIDENCE – Technology developed by EpiVax Therapeutics Inc. will power a new effort to produce individualized, mRNA vaccine-based cancer treatments in a partnership with...

R.I. misses out on $1B in federal funding for economic projects

Business Services 09/02/2022

WASHINGTON (AP) – Ambitions to jump-start the state’s biotech and blue economies with multi-millions in federal funding were dashed on Friday after neither Rhode...